T 2930/19 (Aqueous pharmaceutical compositions containing borate-polyol complexes / NOVARTIS) of 07.10.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T293019.20241007
- Date of decision
- 7 October 2024
- Case number
- T 2930/19
- Petition for review of
- -
- Application number
- 10196245.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Aqueous pharmaceutical compositions containing borate-polyol complexes
- Applicant name
- NOVARTIS AG
- Opponent name
- Generics [UK] Limited (trading as Mylan)
Alfred E. Tiefenbacher (GmbH & Co. KG) - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 76(1)European Patent Convention Art 87(1)Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Amendment to appeal case - amendment overcomes issues raised (yes)
Amendments - added subject-matter (no)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- G 0001/22
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1-10 of the main request filed as auxiliary request 5 with the reply to the appeals of the opponents on 9 June 2020 and a description to be adapted thereto.